We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
National CineMedia
NCMI
$378M
| $1.18M | ﹤0.01% |
7,842
+311
| +4% | +$46.4K |
|
1752
First Merchants
FRME
$2.67B
| $1.18M | ﹤0.01% |
50,189
+1,700
| +4% | +$38.7K |
|
|
TPC
1753
Tutor Perini Cor
TPC
$5.21B
| $1.18M | ﹤0.01% |
50,554
+325
| +0.6% | +$7.63K |
|
1754
Greenlight Captial
GLRE
$506M
| $1.17M | ﹤0.01% |
36,866
-900
| -2% | -$28.9K |
|
1755
ArcBest
ARCB
$3.08B
| $1.17M | ﹤0.01% |
30,902
+3,435
| +13% | +$139K |
|
1756
Regis Corp
RGS
$70.2M
| $1.17M | ﹤0.01% |
3,576
+65
| +2% | +$21.2K |
|
|
TRNX
1757
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $1.17M | ﹤0.01% |
44,570
+1,000
| +2% | +$25.3K |
|
1758
Pilgrim's Pride
PPC
$6.54B
| $1.17M | ﹤0.01% |
51,696
-2,020
| -4% | -$57.4K |
|
|
CRAY
1759
DELISTED
Cray, Inc.
CRAY
| $1.17M | ﹤0.01% |
41,586
+5,485
| +15% | +$174K |
|
1760
Rush Enterprises Class A
RUSHA
$6.22B
| $1.17M | ﹤0.01% |
95,841
+7,200
| +8% | +$91.1K |
|
|
HRG
1761
DELISTED
HRG Group, Inc.
HRG
| $1.17M | ﹤0.01% |
93,366
+6,900
| +8% | +$87.1K |
|
|
EXL
1762
DELISTED
EXCEL TRUST , INC COM STK
EXL
| $1.16M | ﹤0.01% |
82,990
+4,700
| +6% | +$65.3K |
|
1763
ICF International
ICFI
$1.72B
| $1.16M | ﹤0.01% |
28,390
+945
| +3% | +$37.9K |
|
|
VRTU
1764
DELISTED
Virtusa Corporation
VRTU
| $1.16M | ﹤0.01% |
28,042
+4,125
| +17% | +$164K |
|
|
MANT
1765
DELISTED
Mantech International Corp
MANT
| $1.16M | ﹤0.01% |
34,119
+100
| +0.3% | +$3.28K |
|
|
RDS.B
1766
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.16M | ﹤0.01% |
18,422
+33
| +0.2% | +$2.18K |
|
|
MACK
1767
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.15M | ﹤0.01% |
12,347
+2,003
| +19% | +$170K |
|
1768
Toronto Dominion Bank
TD
$200B
| $1.15M | ﹤0.01% |
26,820
-100
| -0.4% | -$4.3K |
|
1769
Chord Energy
CHRD
$7.39B
| $1.15M | ﹤0.01% |
80,762
+2,590
| +3% | +$38K |
|
|
UHT
1770
Universal Health Realty Income Trust
UHT
$594M
| $1.15M | ﹤0.01% |
20,407
+2,300
| +13% | +$120K |
|
|
CBB
1771
DELISTED
Cincinnati Bell Inc.
CBB
| $1.15M | ﹤0.01% |
65,061
+5,398
| +9% | +$89.2K |
|
|
RSTI
1772
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $1.14M | ﹤0.01% |
47,154
+900
| +2% | +$22.6K |
|
|
TUMI
1773
DELISTED
TUMI HLDGS INC COM
TUMI
| $1.14M | ﹤0.01% |
46,680
+7,025
| +18% | +$160K |
|
|
ELGX
1774
DELISTED
Endologix Inc
ELGX
| $1.14M | ﹤0.01% |
6,659
+765
| +13% | +$116K |
|
|
SGMO
1775
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.14M | ﹤0.01% |
72,465
+10,435
| +17% | +$161K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.